Alan
Digital health insurance platform that raised €183M to expand AI-driven healthcare across Europe. Latest funding details, valuation & growth metrics inside.
Overview
Alan is a European healthcare company focused on prevention-oriented insurance, positioning itself as a potential healthcare platform for the region. Its offering targets employers and members seeking health coverage tied to more proactive care. The company’s differentiation centers on combining insurance with preventive health services rather than only reimbursing care after illness. Prosus invested $460 million in an undisclosed round valuing Alan at $6.3 billion, bringing total disclosed funding to $460 million.
Funding History
Prosus pours $460M into Alan at $6.3B: Can prevention insurance become Europe’s next healthcare giant?
Frequently Asked Questions
- How much funding does AI Funding track for Alan?
- AI Funding tracks $460M for Alan across 1 funding round in this database.
- Who are Alan's investors?
- Alan's investors include Index Ventures, Prosus, Teachers’ Venture Growth, Dara Holdings.
- What does Alan do?
- Alan is a European healthcare company focused on prevention-oriented insurance, positioning itself as a potential healthcare platform for the region. Its offering targets employers and members seeking health coverage tied to more proactive care. The company’s differentiation centers on combining insurance with preventive health services rather than only reimbursing care after illness. Prosus invested $460 million in an undisclosed round valuing Alan at $6.3 billion, bringing total disclosed funding to $460 million.
- Where is Alan headquartered?
- Alan is headquartered in Europe.
Investors
Related Insights
A data-driven analysis of AI funding across all 17 sectors — from Foundation Models to AI Healthcare — with sector totals, deal counts, top companies, and investment trends for 2026.
Accel has led rounds for Scale AI, Lovable, and Cyera while backing Cursor. We analyze the firm's $2.8B AI portfolio and multi-layer investment thesis.
A comprehensive, data-driven analysis of AI venture funding in Q1 2026. $25.9 billion raised across 94 deals, with 14 mega-rounds capturing 79.8% of total capital. Europe breaks out with $6.65B, and billion-dollar seed rounds arrive for the first time.